
Novo Nordisk launches Wegovy in India, targets obesity treatment market, offers semaglutide-based weekly injection
Danish pharmaceutical giant Novo Nordisk on Tuesday announced the launch of its anti-obesity drug Wegovy in India, targeting chronic weight management and reduction in major adverse cardiovascular events in adults with obesity or overweight.The launch marks the company’s push into India’s growing obesity market, with Wegovy being made available across urban and rural markets in…